Navigation Links
Symmetry Medical Reports Third Quarter 2008 Financial Results
Date:11/12/2008

Increases Full Year Revenue Guidance to a range of $417 Million to $422 Million

Third Quarter 2008 Highlights:

- Record revenue of $112.1 million, up 47.8% over third quarter 2007

- Gross profit of $25.7 million a 126.8% increase compared to the third quarter 2007

- Net income of $0.07 per share compared to a loss of $0.03 per share in the third quarter 2007

- Net income includes unfavorable impact of foreign exchange, tax loss carry forward, a facility closure costs and Sheffield, UK headcount reduction costs

WARSAW, Ind., Nov. 12 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today third quarter 2008 financial results for the period ended October 4, 2008.

Revenue for the third quarter 2008 was $112.1 million, up 47.8% from $75.8 million reported in the third quarter 2007. Third quarter 2008 revenue included an incremental $4.7 million from SSI and UCA, which was acquired in August 2007; and $14.0 million from the Company's New Bedford, Massachusetts manufacturing facility, which was acquired from DePuy Orthopaedics, Inc. in January 2008. Excluding these acquisitions, the Company achieved organic revenue growth of 23.2% over the third quarter of 2007.

Gross profit for the third quarter 2008 was $25.7 million, an increase of 126.8% from $11.3 million for the third quarter 2007. Gross profit for the third quarter of 2008 was impacted by several unfavorable items which include $0.7 million related to the closure of the Company's Switzerland facility, $0.5 million related to Sheffield headcount reduction and a $0.4 million gross profit reduction in the C
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
2. Symmetry Medical Launches New Global Web site
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
6. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Expand Malaysian Operations
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. Symmetry Medical Reports Full Year 2007 Financial Results
11. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ort Experimental Procedure for Preteen Son - ,... For parents of children with cancer, the hopeful ...y improved for decades. Among the bad news -- trea...y. ,, Boys diagnosed with cancer who have rea...erve their fertility: before undergoing cancer tre...
(Date:11/9/2009)... 9 The American Academy... than 75,000 clinically practicing physician assis...uds the U.S. House of Representatives for passing ...he Affordable Health Care for America Act. ,, "...will ultimately lower the cost of health care and ...
(Date:11/9/2009)...ll use funds to move lab findings into human thera...pain from nerve damage ,, ANN ARBOR, Mich., No...e University of Michigan Department of Neurology h...el therapy for neuropathic pain, a difficult-to-tr...cause of damage to nerve without obvious tissue in...
(Date:11/9/2009)...ilable in French . , , Montreal, November 9,...d female. In human bodies trillions of cells are c...hey are composed. Yet these don,t come in twos, t... Because these complex cell networks are the backb...rched for ways to splice cell clusters down to the...
(Date:11/9/2009)...er 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), t...ay announced the availability of INTUNIV (guanfaci...the United States for the treatment of Attention-D...nd adolescents ages 6 to 17. INTUNIV, a once-dail... nonscheduled alpha-2A receptor agonist approved f...
Breaking Medicine News(10 mins):Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...eces and find liberation,from misconceptions, ster...ctivist seeks funding for national ,road show,aime...ple who need it most, PRINCETON, N.J., Oct. 4 A ...ll,celebrate its 10th Anniversary in Princeton, N....
...l process; provide more options f...ct. 4 The U.S. Food and Drug,Administration today... and,variety of generic drug products available to...ey factor in,lowering drug prices. The Generic Ini...
...ith virtual diabetes health- ... 4 The American,Diabetes Association today unveil...ier for people with diabetes -- and their care pro... software,application developed by a software and ...
...nd personal experiences confirm that events that h...fear, anger and joy are far more memorable than le...Cell, Johns Hopkins researchers and their collabor...primes nerve cells to remember events by increasin...
...ressure and track other health ...an Heart,Association has launched Blood Pressure M... that was built on HealthVault, Microsoft Corp.,s ...,manage their risk for heart disease and stroke, w...
...ernational Medical Corps (IMC) are delivering crit...ponding to the cholera outbreak in that country. ...rhea have spread,through northern Iraq recently, a...untry, there is a shortage of,medicines to control...
Other Medicine News:Health News:10th Anniversary of Revolutionary Teaching Approach that Offers the Severely 'Disabled' the Gift of Self-Expression - Through Painting 2Health News:10th Anniversary of Revolutionary Teaching Approach that Offers the Severely 'Disabled' the Gift of Self-Expression - Through Painting 3Health News:10th Anniversary of Revolutionary Teaching Approach that Offers the Severely 'Disabled' the Gift of Self-Expression - Through Painting 4Health News:10th Anniversary of Revolutionary Teaching Approach that Offers the Severely 'Disabled' the Gift of Self-Expression - Through Painting 5Health News:FDA Announces Initiative to Bolster Generic Drug Program 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4Health News:What emotional memories are made of 2Health News:American Heart Association Announces Debut of Health Management Tool on Microsoft HealthVault 2Health News:American Heart Association Announces Debut of Health Management Tool on Microsoft HealthVault 3Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 2Health News:AmeriCares and International Medical Corps Airlift Relief for Cholera Outbreak In Iraq 3
(Date:11/9/2009)..., Nov. 9 Milestone Scien...zed leader in computer-controlled injection techno... its patented, award-winning STA Single Tooth Ane...oup,s 15th year of TBSE titled "The Love Dentistry... Hilton. ,, The STA System is a computer-co...
(Date:11/9/2009)...ON, N.J., Nov. 9 Unwavering from i..., but recognizing today,s economic climate, Lutron...hetic laser systems, introduces the MOSAIC CO2, a ...r $50,000. ,, The MOSAIC CO2 offers many of th...ogy including scanning and stamping operation mode...
(Date:11/9/2009)..., Nov. 9 Thomson Reuters today a...CareFocus, a leading clinical surveillance solutio...nts in real-time and respond immediately to improv...ent. ,, This upgrade is available to current Ca...areFocus 2.0 contains several powerful enhancement...
Breaking Medicine Technology:Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Lutronic(R) Unleashes the New MOSAIC CO2 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Takes a Pro to Make Offices Pain Free 60246 1Takes a Pro to Make Offices Pain Free 60246 2InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 1InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 1NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 3
...Phase II Trial in Its Bavituximab Cancer P...STIN, Calif., Aug. 11 Peregrine,Pharmaceuticals, ... screening,and dosing has begun in a Phase II tria...bavituximab in combination with chemotherapy in pa...is the second Phase II study,evaluating bavituxima...
...privately-held,biopharmaceutical company, announce...t of three ongoing phase 2 clinical trials sponsor...logies Ltd, to investigate,CollaRx(R) BUPIVACAINE ...ive pain., Innocoll,s BUPIVACAINE SURGICAL IMPLAN...x of purified fibrillar collagen impregnated with ...
Other Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 4Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 2Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 3Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain 4
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar
Soft-Touch Timeter® 8 LPM Flowmeter
Oxygen Dial Flowmeters - Ohmeda
...ine of flowmeters, available in oxygen, air, helio...f calibrations to best suit your application. With...in use, the Amvex Flowmeter is a user friendly dev...ower Take-Off add PT to the end of the part number...
Medicine Products: